TCL Archive FDA approves a new cancer drug, Vidaza, and two sNDAs, without going to ODAC. A date with ODAC may signal a weak case for drug approval, recent approval data indicate. May 28, 2004
TCL Archive HHS, MB, OSTP Urge President To Veto Biomedical Research Authorization; Senate Pushes FTE Levels October 25, 1985